Literature DB >> 9078435

Regulation of myelin oligodendrocyte glycoprotein in different species throughout development.

A J Slavin1, T G Johns, J M Orian, C C Bernard.   

Abstract

The assembly and function of central nervous system (CNS) myelin requires the coordinated expression of several myelin-specific proteins, including myelin oligodendrocyte glycoprotein (MOG). Despite the recent cloning of MOG, the function of this molecule is still unknown. Because MOG is a late marker of oligodendrocyte maturation and is exclusively expressed in the CNS on the outermost lamellae of the myelin membrane, it is possible that this molecule plays an important role in the control and maintenance of myelination. Furthermore, as a member of the immunoglobulin superfamily that carries the L2/HNK-1 epitope, it has also been suggested that MOG is involved in cell-cell interaction, perhaps functioning as an adhesive molecule for bundles of nerve fibres. In order to further delineate the role of MOG throughout development we have analysed, by immunoblotting, the developmental appearance and accumulation pattern of MOG in the CNS of three mammalian species. We have also purified MOG to homogeneity from five different species including rat, guinea pig, bovine, monkey and human. Immunoblotting revealed two major MOG bands at 28 and 55 kD in all species. The 55 kD band appears to be a dimer of the lower band although treatment with 2-mercaptoethanol or EDTA failed to abolish it. Purified MOG from all species also displayed faint reactivity with bands at 36, 48 and 78 kD. While the 78 kD band may represent a trimer of MOG, the identity of the other bands remains unknown. Developmental studies in mouse, rat, guinea pig and bovine showed at as for other myelin proteins, MOG displayed a caudorostral gradient of expression, appearing in the spinal cord before the brain. The sensitivity of the detection system used here allowed us to detect MOG protein earlier than in previous reports such that its presence was clearly demonstrated in the CNS of mice and rats at 14 and 10 days after birth, respectively. Analysis of MOG expression in a novel transgenic mouse model that has both delayed and reduced myelination revealed that, like other myelin proteins, MOG expression was delayed compared with normal littermates. These results demonstrate that the expression of MOG is similar in all species and is regulated in a manner consistent with other myelin-specific proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078435     DOI: 10.1159/000111187

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  11 in total

1.  Clinical and MRI phenotype of children with MOG antibodies.

Authors:  Cristina Fernandez-Carbonell; David Vargas-Lowy; Alexander Musallam; Brian Healy; Katherine McLaughlin; Kai W Wucherpfennig; Tanuja Chitnis
Journal:  Mult Scler       Date:  2015-06-03       Impact factor: 6.312

Review 2.  The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.

Authors:  Hassnae Afrache; Philippe Gouret; Shanaiz Ainouche; Pierre Pontarotti; Daniel Olive
Journal:  Immunogenetics       Date:  2012-09-23       Impact factor: 2.846

3.  MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.

Authors:  Matthias Baumann; Astrid Grams; Tanja Djurdjevic; Eva-Maria Wendel; Christian Lechner; Bettina Behring; Astrid Blaschek; Katharina Diepold; Astrid Eisenkölbl; Joel Fluss; Michael Karenfort; Johannes Koch; Bahadir Konuşkan; Steffen Leiz; Andreas Merkenschlager; Daniela Pohl; Mareike Schimmel; Charlotte Thiels; Barbara Kornek; Kathrin Schanda; Markus Reindl; Kevin Rostásy
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

Review 4.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

5.  Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  Dun Zhou; Rajneesh Srivastava; Stefan Nessler; Verena Grummel; Norbert Sommer; Wolfgang Brück; Hans-Peter Hartung; Christine Stadelmann; Bernhard Hemmer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

6.  Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.

Authors:  Yossi Gilgun-Sherki; Yael Barhum; Daphne Atlas; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.

Authors:  Craig S Clements; Hugh H Reid; Travis Beddoe; Fleur E Tynan; Matthew A Perugini; Terrance G Johns; Claude C A Bernard; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis.

Authors:  Katherine A McLaughlin; Tanuja Chitnis; Jia Newcombe; Bettina Franz; Julia Kennedy; Shannon McArdel; Jens Kuhle; Ludwig Kappos; Kevin Rostasy; Daniela Pohl; Donald Gagne; Jayne M Ness; Silvia Tenembaum; Kevin C O'Connor; Vissia Viglietta; Susan J Wong; Norma P Tavakoli; Jerome de Seze; Zhannat Idrissova; Samia J Khoury; Amit Bar-Or; David A Hafler; Brenda Banwell; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-08-17       Impact factor: 5.422

9.  Differential responses of hippocampal neurons and astrocytes to nicotine and hypoxia in the fetal guinea pig.

Authors:  Tamara Blutstein; Michael A Castello; Shaun S Viechweg; Maria M Hadjimarkou; Joseph A McQuail; Mary Holder; Loren P Thompson; Jessica A Mong
Journal:  Neurotox Res       Date:  2012-11-29       Impact factor: 3.911

10.  Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.

Authors:  Courtney A McDonald; Natalie L Payne; Guizhi Sun; Leon Moussa; Christopher Siatskas; Rebecca Lim; Euan M Wallace; Graham Jenkin; Claude C A Bernard
Journal:  J Neuroinflammation       Date:  2015-06-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.